Kenneth MacLean
Concepts (450)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Homocystinuria | 14 | 2024 | 70 | 6.360 |
Why?
| Cystathionine beta-Synthase | 22 | 2024 | 69 | 4.920 |
Why?
| Taurine | 6 | 2020 | 41 | 2.670 |
Why?
| Liver | 16 | 2024 | 1832 | 2.410 |
Why?
| Betaine | 10 | 2024 | 72 | 2.370 |
Why?
| Homocysteine | 12 | 2024 | 150 | 1.730 |
Why?
| Betaine-Homocysteine S-Methyltransferase | 2 | 2019 | 11 | 1.020 |
Why?
| Oxidation-Reduction | 6 | 2024 | 1013 | 0.990 |
Why?
| Tetrahydrofolate Dehydrogenase | 1 | 2024 | 22 | 0.920 |
Why?
| Tetrahydrofolates | 1 | 2024 | 18 | 0.920 |
Why?
| Methionine | 4 | 2021 | 158 | 0.900 |
Why?
| Down Syndrome | 10 | 2023 | 454 | 0.870 |
Why?
| Disease Models, Animal | 21 | 2024 | 3994 | 0.830 |
Why?
| Mice | 42 | 2024 | 16543 | 0.780 |
Why?
| Mice, Inbred C57BL | 21 | 2024 | 5270 | 0.710 |
Why?
| Cysteine | 4 | 2020 | 190 | 0.690 |
Why?
| Fatty Liver | 6 | 2013 | 230 | 0.630 |
Why?
| Sulfur | 2 | 2014 | 50 | 0.620 |
Why?
| Sulfinic Acids | 1 | 2018 | 8 | 0.590 |
Why?
| Animals | 48 | 2024 | 34628 | 0.590 |
Why?
| Choline | 2 | 2017 | 117 | 0.590 |
Why?
| Sulfhydryl Compounds | 2 | 2018 | 188 | 0.580 |
Why?
| Aminobutyrates | 1 | 2018 | 33 | 0.580 |
Why?
| Pyruvaldehyde | 1 | 2018 | 32 | 0.570 |
Why?
| Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.560 |
Why?
| Endoplasmic Reticulum | 5 | 2014 | 256 | 0.550 |
Why?
| Non-alcoholic Fatty Liver Disease | 4 | 2024 | 255 | 0.500 |
Why?
| Mice, Knockout | 10 | 2020 | 2770 | 0.490 |
Why?
| Cystathionine | 2 | 2012 | 25 | 0.490 |
Why?
| Phospholipids | 1 | 2017 | 209 | 0.490 |
Why?
| Induced Pluripotent Stem Cells | 3 | 2023 | 219 | 0.480 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2021 | 35 | 0.480 |
Why?
| Apolipoprotein A-I | 2 | 2012 | 29 | 0.470 |
Why?
| Hepatocytes | 3 | 2024 | 215 | 0.450 |
Why?
| Thrombosis | 2 | 2011 | 331 | 0.450 |
Why?
| Neural Stem Cells | 4 | 2023 | 132 | 0.440 |
Why?
| Apolipoproteins A | 1 | 2012 | 19 | 0.400 |
Why?
| Aryldialkylphosphatase | 1 | 2012 | 18 | 0.390 |
Why?
| Mice, Transgenic | 10 | 2021 | 2073 | 0.380 |
Why?
| Fragile X Syndrome | 2 | 2009 | 73 | 0.370 |
Why?
| Folic Acid | 2 | 2024 | 182 | 0.370 |
Why?
| Hydrogen Sulfide | 2 | 2020 | 41 | 0.340 |
Why?
| Chemokines | 1 | 2011 | 227 | 0.340 |
Why?
| Trans-Activators | 3 | 2007 | 387 | 0.330 |
Why?
| Transcription Factors | 9 | 2013 | 1634 | 0.330 |
Why?
| Hyperglycinemia, Nonketotic | 2 | 2024 | 48 | 0.330 |
Why?
| Lipids | 1 | 2012 | 614 | 0.310 |
Why?
| Male | 33 | 2024 | 63146 | 0.300 |
Why?
| S-Adenosylmethionine | 6 | 2006 | 58 | 0.300 |
Why?
| Mutation | 8 | 2024 | 3671 | 0.300 |
Why?
| Endoplasmic Reticulum Stress | 3 | 2014 | 98 | 0.300 |
Why?
| Biomarkers | 2 | 2019 | 3874 | 0.300 |
Why?
| Dietary Supplements | 4 | 2014 | 533 | 0.290 |
Why?
| Urination Disorders | 1 | 2007 | 13 | 0.280 |
Why?
| Apoptosis | 3 | 2013 | 2481 | 0.280 |
Why?
| Saccharomyces cerevisiae | 2 | 2002 | 517 | 0.280 |
Why?
| Ectodermal Dysplasia | 1 | 2007 | 16 | 0.280 |
Why?
| Cleft Lip | 1 | 2007 | 42 | 0.270 |
Why?
| Fingers | 1 | 2007 | 87 | 0.270 |
Why?
| Myoblasts | 1 | 2007 | 76 | 0.270 |
Why?
| Cleft Palate | 1 | 2007 | 63 | 0.260 |
Why?
| Metabolome | 2 | 2021 | 316 | 0.260 |
Why?
| Protein Precursors | 1 | 2007 | 126 | 0.260 |
Why?
| Abnormalities, Multiple | 2 | 2007 | 178 | 0.260 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2021 | 289 | 0.260 |
Why?
| DNA-Binding Proteins | 4 | 2007 | 1423 | 0.260 |
Why?
| Oxidative Stress | 6 | 2022 | 1220 | 0.250 |
Why?
| Cystathionine gamma-Lyase | 3 | 2020 | 11 | 0.250 |
Why?
| Carbon | 2 | 2024 | 205 | 0.250 |
Why?
| Muscle Fibers, Skeletal | 1 | 2007 | 187 | 0.250 |
Why?
| Amino Acids | 2 | 2020 | 469 | 0.240 |
Why?
| Trisomy | 4 | 2017 | 75 | 0.240 |
Why?
| Tumor Suppressor Proteins | 1 | 2007 | 313 | 0.230 |
Why?
| Phenotype | 5 | 2024 | 3059 | 0.230 |
Why?
| Sp1 Transcription Factor | 1 | 2003 | 25 | 0.220 |
Why?
| Female | 23 | 2024 | 68162 | 0.220 |
Why?
| Nuclear Proteins | 2 | 2013 | 644 | 0.220 |
Why?
| Glycine | 1 | 2024 | 162 | 0.210 |
Why?
| Humans | 38 | 2024 | 128896 | 0.210 |
Why?
| Myocytes, Cardiac | 1 | 2007 | 484 | 0.210 |
Why?
| Uterine Artery | 2 | 2020 | 74 | 0.200 |
Why?
| Connective Tissue | 1 | 2002 | 38 | 0.200 |
Why?
| Cells | 1 | 2002 | 24 | 0.200 |
Why?
| Diet, High-Fat | 2 | 2024 | 240 | 0.190 |
Why?
| Adenosylhomocysteinase | 1 | 2021 | 10 | 0.180 |
Why?
| Glycine Hydroxymethyltransferase | 1 | 2021 | 16 | 0.180 |
Why?
| Heme | 2 | 2002 | 77 | 0.180 |
Why?
| tau Proteins | 2 | 2012 | 78 | 0.180 |
Why?
| Stress, Psychological | 1 | 2009 | 1051 | 0.180 |
Why?
| Polyamines | 1 | 2021 | 39 | 0.180 |
Why?
| Insulin Resistance | 2 | 2024 | 1163 | 0.180 |
Why?
| Mitochondria | 3 | 2023 | 837 | 0.180 |
Why?
| Liver Failure | 1 | 2021 | 90 | 0.170 |
Why?
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.170 |
Why?
| Lipotropic Agents | 2 | 2012 | 5 | 0.170 |
Why?
| Leigh Disease | 1 | 2020 | 19 | 0.170 |
Why?
| Quinone Reductases | 1 | 2020 | 17 | 0.170 |
Why?
| Mutation, Missense | 1 | 2002 | 319 | 0.170 |
Why?
| Myometrium | 1 | 2020 | 35 | 0.170 |
Why?
| Association Learning | 2 | 2011 | 62 | 0.170 |
Why?
| Lipogenesis | 3 | 2019 | 56 | 0.170 |
Why?
| Ethanol | 2 | 2016 | 577 | 0.170 |
Why?
| Growth Differentiation Factor 10 | 1 | 2019 | 1 | 0.160 |
Why?
| SNARE Proteins | 1 | 2019 | 38 | 0.160 |
Why?
| Umbilical Arteries | 1 | 2020 | 49 | 0.160 |
Why?
| Cell Differentiation | 6 | 2023 | 1854 | 0.160 |
Why?
| Interleukin-1beta | 2 | 2011 | 376 | 0.160 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2018 | 168 | 0.150 |
Why?
| Myocytes, Smooth Muscle | 1 | 2020 | 246 | 0.150 |
Why?
| Hyperhomocysteinemia | 2 | 2009 | 26 | 0.150 |
Why?
| Glutathione | 3 | 2020 | 333 | 0.150 |
Why?
| PPAR gamma | 1 | 2019 | 182 | 0.150 |
Why?
| Recombinant Proteins | 2 | 2001 | 1304 | 0.150 |
Why?
| gamma-Glutamyltransferase | 1 | 2018 | 40 | 0.150 |
Why?
| Respiratory Hypersensitivity | 1 | 2018 | 64 | 0.140 |
Why?
| Brachial Artery | 1 | 2019 | 205 | 0.140 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2011 | 1204 | 0.140 |
Why?
| Proteostasis Deficiencies | 1 | 2017 | 6 | 0.140 |
Why?
| Hep G2 Cells | 2 | 2019 | 61 | 0.140 |
Why?
| Autophagy | 1 | 2019 | 263 | 0.140 |
Why?
| Inflammation | 4 | 2019 | 2694 | 0.140 |
Why?
| Estradiol | 1 | 2020 | 494 | 0.140 |
Why?
| Cell Death | 2 | 2024 | 342 | 0.130 |
Why?
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.130 |
Why?
| Fatty Liver, Alcoholic | 1 | 2016 | 14 | 0.130 |
Why?
| Fibroblasts | 4 | 2012 | 946 | 0.130 |
Why?
| Animals, Newborn | 4 | 2024 | 813 | 0.130 |
Why?
| Transcription Factor TFIIIB | 1 | 1995 | 1 | 0.130 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 1995 | 18 | 0.130 |
Why?
| Molecular Sequence Data | 6 | 2003 | 2842 | 0.130 |
Why?
| Obesity | 3 | 2024 | 2844 | 0.120 |
Why?
| Cells, Cultured | 6 | 2022 | 4048 | 0.120 |
Why?
| RNA, Messenger | 4 | 2014 | 2700 | 0.120 |
Why?
| Diet | 3 | 2011 | 1205 | 0.120 |
Why?
| PTEN Phosphohydrolase | 1 | 2016 | 148 | 0.120 |
Why?
| Brain | 4 | 2024 | 2592 | 0.120 |
Why?
| Child, Preschool | 5 | 2020 | 10457 | 0.120 |
Why?
| Host Cell Factor C1 | 1 | 2014 | 14 | 0.120 |
Why?
| Cysteine Dioxygenase | 1 | 2014 | 3 | 0.120 |
Why?
| Escherichia coli | 4 | 2002 | 782 | 0.120 |
Why?
| Carboxy-Lyases | 1 | 2014 | 8 | 0.120 |
Why?
| Antigens, Polyomavirus Transforming | 1 | 1994 | 17 | 0.110 |
Why?
| Protein Processing, Post-Translational | 1 | 2017 | 448 | 0.110 |
Why?
| Cell Transformation, Viral | 1 | 1994 | 28 | 0.110 |
Why?
| Fetal Growth Retardation | 1 | 2020 | 542 | 0.110 |
Why?
| Triglycerides | 5 | 2018 | 519 | 0.110 |
Why?
| Li-Fraumeni Syndrome | 1 | 1994 | 13 | 0.110 |
Why?
| Protein Denaturation | 2 | 2012 | 73 | 0.110 |
Why?
| Sulfurtransferases | 1 | 2013 | 9 | 0.110 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2018 | 544 | 0.110 |
Why?
| Glutaredoxins | 1 | 2013 | 12 | 0.110 |
Why?
| Base Sequence | 6 | 2003 | 2157 | 0.110 |
Why?
| Heat-Shock Proteins | 1 | 2014 | 128 | 0.110 |
Why?
| Cognition | 2 | 2012 | 1093 | 0.110 |
Why?
| Cholesterol | 2 | 2013 | 399 | 0.110 |
Why?
| Liver Diseases, Alcoholic | 1 | 2014 | 87 | 0.110 |
Why?
| Cell Line | 3 | 2019 | 2759 | 0.110 |
Why?
| Adenosine Triphosphatases | 1 | 2014 | 164 | 0.110 |
Why?
| Peroxiredoxins | 1 | 2013 | 24 | 0.110 |
Why?
| Aldehydes | 1 | 2014 | 140 | 0.110 |
Why?
| Adult | 6 | 2020 | 35361 | 0.110 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 326 | 0.110 |
Why?
| Blotting, Western | 2 | 2014 | 1188 | 0.100 |
Why?
| Avoidance Learning | 2 | 2012 | 66 | 0.100 |
Why?
| Tunicamycin | 1 | 2012 | 11 | 0.100 |
Why?
| Carboxylic Ester Hydrolases | 1 | 2012 | 19 | 0.100 |
Why?
| Galantamine | 1 | 2011 | 3 | 0.100 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 957 | 0.100 |
Why?
| Lyases | 1 | 2012 | 9 | 0.100 |
Why?
| Metabolomics | 1 | 2017 | 592 | 0.100 |
Why?
| Fragile X Mental Retardation Protein | 2 | 2009 | 55 | 0.100 |
Why?
| Young Adult | 3 | 2020 | 12286 | 0.100 |
Why?
| Zebrafish Proteins | 1 | 2014 | 258 | 0.100 |
Why?
| Palmitic Acid | 1 | 2011 | 40 | 0.090 |
Why?
| Child | 4 | 2019 | 20824 | 0.090 |
Why?
| AMP-Activated Protein Kinases | 1 | 2013 | 187 | 0.090 |
Why?
| Promoter Regions, Genetic | 4 | 2005 | 1194 | 0.090 |
Why?
| Necrosis | 1 | 2012 | 234 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2014 | 816 | 0.090 |
Why?
| Chemokine CCL4 | 1 | 2011 | 21 | 0.090 |
Why?
| Adolescent | 3 | 2019 | 20197 | 0.090 |
Why?
| Sucrose | 1 | 2011 | 93 | 0.090 |
Why?
| Hypoxia | 1 | 2018 | 1070 | 0.090 |
Why?
| Neuroblastoma | 1 | 2012 | 152 | 0.090 |
Why?
| Proteins | 2 | 2013 | 945 | 0.090 |
Why?
| Methylation | 1 | 2011 | 227 | 0.090 |
Why?
| Dietary Fats | 1 | 2013 | 302 | 0.090 |
Why?
| Interleukin-1alpha | 1 | 2011 | 56 | 0.090 |
Why?
| Stem Cell Transplantation | 1 | 2012 | 167 | 0.090 |
Why?
| Cell Line, Tumor | 2 | 2011 | 3100 | 0.090 |
Why?
| Kinetics | 4 | 2020 | 1619 | 0.090 |
Why?
| Interleukin-17 | 1 | 2011 | 107 | 0.090 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 2010 | 39 | 0.090 |
Why?
| Carrier Proteins | 1 | 2014 | 728 | 0.090 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 2011 | 136 | 0.080 |
Why?
| Blood Coagulation | 1 | 2011 | 228 | 0.080 |
Why?
| Serine Endopeptidases | 1 | 2010 | 113 | 0.080 |
Why?
| Hemostasis | 1 | 2010 | 68 | 0.080 |
Why?
| HEK293 Cells | 1 | 2012 | 673 | 0.080 |
Why?
| Alcohol Drinking | 1 | 2016 | 742 | 0.080 |
Why?
| Cell Division | 2 | 2002 | 800 | 0.080 |
Why?
| Freezing Reaction, Cataleptic | 1 | 2009 | 22 | 0.080 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 2 | 2024 | 57 | 0.080 |
Why?
| Acetylcysteine | 1 | 2010 | 148 | 0.080 |
Why?
| Extracellular Matrix Proteins | 1 | 2010 | 144 | 0.080 |
Why?
| Hippocampus | 2 | 2012 | 785 | 0.080 |
Why?
| Swimming | 1 | 2009 | 47 | 0.080 |
Why?
| Restraint, Physical | 1 | 2009 | 67 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 2 | 2007 | 356 | 0.080 |
Why?
| Electroshock | 1 | 2009 | 143 | 0.080 |
Why?
| Hypertriglyceridemia | 1 | 2009 | 39 | 0.080 |
Why?
| Atherosclerosis | 1 | 2013 | 392 | 0.080 |
Why?
| Tumor Cells, Cultured | 3 | 2002 | 928 | 0.080 |
Why?
| Genetic Variation | 1 | 2013 | 935 | 0.080 |
Why?
| Rats | 4 | 2011 | 5236 | 0.080 |
Why?
| Blood Coagulation Disorders | 1 | 2010 | 163 | 0.080 |
Why?
| Embryonic Development | 2 | 2006 | 118 | 0.070 |
Why?
| Corticosterone | 1 | 2009 | 214 | 0.070 |
Why?
| Liver Cirrhosis | 1 | 2010 | 274 | 0.070 |
Why?
| Cognition Disorders | 1 | 2012 | 496 | 0.070 |
Why?
| Gene Expression Regulation | 4 | 2019 | 2520 | 0.070 |
Why?
| Infant | 5 | 2019 | 8994 | 0.070 |
Why?
| Exploratory Behavior | 1 | 2008 | 85 | 0.070 |
Why?
| Fibrosis | 1 | 2010 | 518 | 0.070 |
Why?
| Memory | 1 | 2009 | 231 | 0.070 |
Why?
| Interleukin-6 | 1 | 2011 | 715 | 0.070 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 32 | 0.070 |
Why?
| Aging | 3 | 2012 | 1767 | 0.070 |
Why?
| Taste | 1 | 2009 | 214 | 0.070 |
Why?
| Pregnancy | 5 | 2020 | 6247 | 0.070 |
Why?
| Glutamine | 1 | 2007 | 94 | 0.070 |
Why?
| Lamin Type A | 1 | 2007 | 48 | 0.070 |
Why?
| Attention | 1 | 2010 | 434 | 0.070 |
Why?
| Nerve Tissue Proteins | 1 | 2010 | 568 | 0.070 |
Why?
| Point Mutation | 1 | 2007 | 226 | 0.070 |
Why?
| Syndrome | 1 | 2007 | 342 | 0.070 |
Why?
| Pedigree | 1 | 2007 | 491 | 0.060 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2006 | 36 | 0.060 |
Why?
| Glucose-6-Phosphatase | 1 | 2005 | 31 | 0.060 |
Why?
| Structure-Activity Relationship | 1 | 2007 | 539 | 0.060 |
Why?
| Placental Circulation | 1 | 2006 | 63 | 0.060 |
Why?
| Arginine | 1 | 2007 | 254 | 0.060 |
Why?
| Social Behavior | 1 | 2008 | 283 | 0.060 |
Why?
| Cloning, Molecular | 3 | 2001 | 536 | 0.060 |
Why?
| Amino Acid Sequence | 3 | 2014 | 2047 | 0.060 |
Why?
| Models, Biological | 1 | 2012 | 1702 | 0.060 |
Why?
| Emotions | 1 | 2010 | 536 | 0.060 |
Why?
| Neovascularization, Physiologic | 1 | 2006 | 179 | 0.060 |
Why?
| Sp3 Transcription Factor | 1 | 2003 | 6 | 0.060 |
Why?
| Trophoblasts | 1 | 2006 | 186 | 0.060 |
Why?
| Serum Albumin | 1 | 2004 | 145 | 0.060 |
Why?
| Alanine Transaminase | 2 | 2016 | 147 | 0.060 |
Why?
| Organ Specificity | 1 | 2003 | 296 | 0.050 |
Why?
| Hydrocephalus | 1 | 2024 | 104 | 0.050 |
Why?
| DNA Primers | 3 | 2005 | 522 | 0.050 |
Why?
| Repressor Proteins | 1 | 2006 | 400 | 0.050 |
Why?
| Blood Physiological Phenomena | 1 | 2002 | 13 | 0.050 |
Why?
| Carbon-Carbon Ligases | 1 | 2002 | 2 | 0.050 |
Why?
| Biopolymers | 1 | 2002 | 32 | 0.050 |
Why?
| Propionates | 1 | 2002 | 34 | 0.050 |
Why?
| DNA, Complementary | 2 | 2000 | 270 | 0.050 |
Why?
| Enzyme Stability | 1 | 2002 | 68 | 0.050 |
Why?
| Cricetulus | 1 | 2002 | 100 | 0.050 |
Why?
| Reperfusion Injury | 1 | 2004 | 274 | 0.050 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 1701 | 0.050 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2002 | 85 | 0.050 |
Why?
| Sequence Homology, Amino Acid | 2 | 2000 | 369 | 0.050 |
Why?
| Genotype | 1 | 2007 | 1834 | 0.050 |
Why?
| Cricetinae | 1 | 2002 | 275 | 0.050 |
Why?
| United States | 1 | 2019 | 13975 | 0.050 |
Why?
| Green Fluorescent Proteins | 2 | 2014 | 392 | 0.050 |
Why?
| Isoenzymes | 1 | 2002 | 303 | 0.050 |
Why?
| DNA Mutational Analysis | 1 | 2002 | 391 | 0.050 |
Why?
| Anxiety | 1 | 2008 | 947 | 0.050 |
Why?
| Pyridoxal Phosphate | 1 | 2000 | 19 | 0.040 |
Why?
| In Situ Hybridization, Fluorescence | 2 | 2006 | 319 | 0.040 |
Why?
| Chromosome Mapping | 2 | 2006 | 503 | 0.040 |
Why?
| Glucose | 1 | 2005 | 976 | 0.040 |
Why?
| Electron Transport Complex IV | 1 | 2020 | 57 | 0.040 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 325 | 0.040 |
Why?
| Reactive Oxygen Species | 1 | 2023 | 575 | 0.040 |
Why?
| Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 27 | 0.040 |
Why?
| R-SNARE Proteins | 1 | 2019 | 18 | 0.040 |
Why?
| Acidosis, Lactic | 1 | 2020 | 44 | 0.040 |
Why?
| Ovariectomy | 1 | 2020 | 135 | 0.040 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 126 | 0.040 |
Why?
| Down-Regulation | 1 | 2002 | 637 | 0.040 |
Why?
| Homozygote | 1 | 2020 | 192 | 0.040 |
Why?
| Pregnancy Trimester, Third | 1 | 2020 | 105 | 0.040 |
Why?
| Mice, Mutant Strains | 2 | 2011 | 291 | 0.040 |
Why?
| Catalysis | 1 | 2000 | 307 | 0.040 |
Why?
| Infant, Small for Gestational Age | 1 | 2020 | 83 | 0.040 |
Why?
| Ultrasonography, Doppler | 1 | 2020 | 118 | 0.040 |
Why?
| Lysosomes | 1 | 2019 | 139 | 0.040 |
Why?
| Brain Diseases | 1 | 2020 | 132 | 0.040 |
Why?
| Sequence Deletion | 2 | 2002 | 180 | 0.040 |
Why?
| Progesterone | 1 | 2020 | 244 | 0.040 |
Why?
| Behavior, Animal | 2 | 2012 | 482 | 0.040 |
Why?
| Macaca | 1 | 2018 | 53 | 0.040 |
Why?
| Citric Acid Cycle | 1 | 2018 | 50 | 0.040 |
Why?
| Polymerase Chain Reaction | 2 | 2005 | 1045 | 0.040 |
Why?
| Infant, Newborn | 2 | 2020 | 5704 | 0.040 |
Why?
| Microtubule-Associated Proteins | 1 | 2019 | 182 | 0.040 |
Why?
| Ligands | 1 | 2000 | 614 | 0.040 |
Why?
| Gluconeogenesis | 1 | 2018 | 73 | 0.040 |
Why?
| Protein Transport | 1 | 2019 | 423 | 0.040 |
Why?
| Diet, Western | 1 | 2018 | 79 | 0.040 |
Why?
| Ultrasonography, Prenatal | 1 | 2020 | 266 | 0.040 |
Why?
| Estrogens | 1 | 2020 | 348 | 0.040 |
Why?
| Ultraviolet Rays | 1 | 2000 | 385 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2020 | 379 | 0.040 |
Why?
| Mass Spectrometry | 1 | 2000 | 659 | 0.030 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2017 | 39 | 0.030 |
Why?
| Homeostasis | 1 | 2020 | 604 | 0.030 |
Why?
| Protein Structure, Tertiary | 2 | 2014 | 832 | 0.030 |
Why?
| Gestational Age | 1 | 2020 | 857 | 0.030 |
Why?
| Alternative Splicing | 1 | 1998 | 215 | 0.030 |
Why?
| Fatty Acids | 1 | 2019 | 415 | 0.030 |
Why?
| RNA-Binding Proteins | 1 | 2019 | 382 | 0.030 |
Why?
| Protein Carbonylation | 1 | 2016 | 53 | 0.030 |
Why?
| Hybrid Cells | 1 | 1995 | 50 | 0.030 |
Why?
| TATA-Binding Protein Associated Factors | 1 | 1995 | 19 | 0.030 |
Why?
| Immunohistochemistry | 2 | 2012 | 1694 | 0.030 |
Why?
| Fatty Acids, Unsaturated | 1 | 2016 | 93 | 0.030 |
Why?
| Family | 1 | 2020 | 650 | 0.030 |
Why?
| Quantitative Trait Loci | 1 | 2018 | 355 | 0.030 |
Why?
| T-Lymphocytes | 1 | 2024 | 1905 | 0.030 |
Why?
| Genes, Immediate-Early | 1 | 1995 | 19 | 0.030 |
Why?
| Pilot Projects | 1 | 2020 | 1545 | 0.030 |
Why?
| Immediate-Early Proteins | 1 | 1995 | 58 | 0.030 |
Why?
| Branchial Region | 1 | 2014 | 35 | 0.030 |
Why?
| Unfolded Protein Response | 1 | 2014 | 48 | 0.030 |
Why?
| Craniofacial Abnormalities | 1 | 2014 | 62 | 0.030 |
Why?
| Oxidoreductases | 1 | 2014 | 91 | 0.030 |
Why?
| Genes, p53 | 1 | 1994 | 69 | 0.030 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 418 | 0.030 |
Why?
| Vitamin B 12 | 1 | 2014 | 120 | 0.030 |
Why?
| Body Patterning | 1 | 2014 | 128 | 0.030 |
Why?
| Middle Aged | 2 | 2007 | 30977 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2014 | 315 | 0.030 |
Why?
| Neural Crest | 1 | 2014 | 120 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 165 | 0.030 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2013 | 33 | 0.030 |
Why?
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.030 |
Why?
| Fatal Outcome | 1 | 2013 | 301 | 0.030 |
Why?
| DNA Methylation | 1 | 2018 | 600 | 0.030 |
Why?
| Protein Folding | 1 | 2014 | 261 | 0.030 |
Why?
| 3T3-L1 Cells | 1 | 2012 | 34 | 0.030 |
Why?
| Gene Expression | 1 | 2018 | 1476 | 0.030 |
Why?
| Drinking Behavior | 1 | 2012 | 11 | 0.020 |
Why?
| Thermogenesis | 1 | 2012 | 44 | 0.020 |
Why?
| Cellular Senescence | 1 | 1994 | 176 | 0.020 |
Why?
| Enzyme Activation | 2 | 2006 | 811 | 0.020 |
Why?
| Chondrocytes | 1 | 2014 | 203 | 0.020 |
Why?
| Dentate Gyrus | 1 | 2012 | 29 | 0.020 |
Why?
| Cell Size | 1 | 2012 | 86 | 0.020 |
Why?
| Maze Learning | 1 | 2012 | 93 | 0.020 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 1995 | 367 | 0.020 |
Why?
| Organ Size | 1 | 2013 | 446 | 0.020 |
Why?
| Neuroimmunomodulation | 1 | 2012 | 67 | 0.020 |
Why?
| Activating Transcription Factor 4 | 1 | 2012 | 20 | 0.020 |
Why?
| Insulin | 1 | 2002 | 2311 | 0.020 |
Why?
| Nootropic Agents | 1 | 2011 | 28 | 0.020 |
Why?
| Transfection | 1 | 1994 | 904 | 0.020 |
Why?
| Mitochondrial Proteins | 1 | 2013 | 234 | 0.020 |
Why?
| Cell Count | 1 | 2012 | 316 | 0.020 |
Why?
| Mice, Inbred C3H | 1 | 2011 | 279 | 0.020 |
Why?
| Signal Transduction | 2 | 2016 | 4857 | 0.020 |
Why?
| Adiponectin | 1 | 2013 | 232 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2012 | 223 | 0.020 |
Why?
| Odorants | 1 | 2011 | 147 | 0.020 |
Why?
| Zebrafish | 1 | 2014 | 448 | 0.020 |
Why?
| Stem Cells | 1 | 2014 | 572 | 0.020 |
Why?
| Cell Movement | 1 | 2014 | 932 | 0.020 |
Why?
| Binding Sites | 2 | 2006 | 1238 | 0.020 |
Why?
| Computer Simulation | 1 | 2014 | 943 | 0.020 |
Why?
| Time Factors | 1 | 2000 | 6568 | 0.020 |
Why?
| Sinus of Valsalva | 1 | 2009 | 11 | 0.020 |
Why?
| Cohort Studies | 1 | 2020 | 5394 | 0.020 |
Why?
| Random Allocation | 1 | 2010 | 351 | 0.020 |
Why?
| Analysis of Variance | 1 | 2012 | 1283 | 0.020 |
Why?
| Apolipoproteins E | 1 | 2009 | 76 | 0.020 |
Why?
| Models, Molecular | 1 | 2014 | 1477 | 0.020 |
Why?
| Lactation | 1 | 2010 | 168 | 0.020 |
Why?
| Cell Survival | 1 | 2012 | 1082 | 0.020 |
Why?
| Immunoblotting | 1 | 2009 | 302 | 0.020 |
Why?
| Cholesterol, HDL | 1 | 2009 | 203 | 0.020 |
Why?
| Visual Perception | 1 | 2010 | 161 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2020 | 3348 | 0.020 |
Why?
| Rats, Sprague-Dawley | 2 | 2004 | 2308 | 0.020 |
Why?
| Protein Binding | 1 | 2014 | 2086 | 0.020 |
Why?
| Transcription, Genetic | 2 | 2006 | 1408 | 0.020 |
Why?
| Choline Deficiency | 1 | 2007 | 11 | 0.020 |
Why?
| Time | 1 | 2007 | 75 | 0.020 |
Why?
| Acute-Phase Reaction | 1 | 2007 | 39 | 0.020 |
Why?
| Cytochrome P-450 CYP2E1 | 1 | 2007 | 26 | 0.020 |
Why?
| Eukaryotic Initiation Factor-2 | 1 | 2007 | 28 | 0.020 |
Why?
| Transcription Factor CHOP | 1 | 2007 | 29 | 0.020 |
Why?
| eIF-2 Kinase | 1 | 2007 | 30 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 424 | 0.020 |
Why?
| Lipase | 1 | 2007 | 63 | 0.020 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 159 | 0.020 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 29 | 0.020 |
Why?
| Energy Metabolism | 1 | 2012 | 837 | 0.020 |
Why?
| Tyrosine | 1 | 2007 | 219 | 0.020 |
Why?
| Animals, Genetically Modified | 1 | 2007 | 232 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2009 | 1230 | 0.020 |
Why?
| Solvents | 1 | 2006 | 107 | 0.020 |
Why?
| Snail Family Transcription Factors | 1 | 2006 | 17 | 0.020 |
Why?
| Placentation | 1 | 2006 | 44 | 0.020 |
Why?
| Blotting, Southern | 1 | 2006 | 69 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2009 | 491 | 0.020 |
Why?
| Karyotyping | 1 | 2006 | 107 | 0.020 |
Why?
| Gene Duplication | 1 | 2006 | 67 | 0.020 |
Why?
| Executive Function | 1 | 2010 | 420 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2013 | 2767 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 2006 | 191 | 0.020 |
Why?
| Tetralogy of Fallot | 1 | 2006 | 79 | 0.010 |
Why?
| Alzheimer Disease | 1 | 2010 | 509 | 0.010 |
Why?
| Aorta | 1 | 2007 | 410 | 0.010 |
Why?
| Rats, Wistar | 1 | 2005 | 396 | 0.010 |
Why?
| Kidney | 1 | 2012 | 1330 | 0.010 |
Why?
| Mothers | 1 | 2010 | 723 | 0.010 |
Why?
| NF-kappa B | 1 | 2007 | 685 | 0.010 |
Why?
| Triamcinolone | 1 | 2002 | 15 | 0.010 |
Why?
| Body Weight | 1 | 2007 | 931 | 0.010 |
Why?
| Liver Neoplasms, Experimental | 1 | 2002 | 28 | 0.010 |
Why?
| Biotinylation | 1 | 2002 | 27 | 0.010 |
Why?
| Holoenzymes | 1 | 2002 | 21 | 0.010 |
Why?
| Amino Acid Metabolism, Inborn Errors | 1 | 2002 | 21 | 0.010 |
Why?
| Dimerization | 1 | 2002 | 189 | 0.010 |
Why?
| Mutagenesis | 1 | 2002 | 178 | 0.010 |
Why?
| Phosphorylation | 1 | 2005 | 1685 | 0.010 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2002 | 170 | 0.010 |
Why?
| Catalytic Domain | 1 | 2001 | 217 | 0.010 |
Why?
| Carcinoma, Hepatocellular | 1 | 2002 | 267 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 2002 | 640 | 0.010 |
Why?
| Placenta | 1 | 2006 | 706 | 0.010 |
Why?
| Hot Temperature | 1 | 2001 | 362 | 0.010 |
Why?
| Minisatellite Repeats | 1 | 1998 | 40 | 0.010 |
Why?
| Alu Elements | 1 | 1998 | 27 | 0.010 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1998 | 150 | 0.010 |
Why?
| Exons | 1 | 1998 | 330 | 0.010 |
Why?
| Liver Neoplasms | 1 | 2002 | 637 | 0.010 |
Why?
| Treatment Outcome | 1 | 2010 | 10239 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 1998 | 778 | 0.010 |
Why?
| Polymorphism, Genetic | 1 | 1998 | 641 | 0.010 |
Why?
| Tristetraprolin | 1 | 1995 | 5 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2002 | 1206 | 0.010 |
Why?
| Blood Glucose | 1 | 2002 | 2086 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|